Your browser doesn't support javascript.
loading
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.
Dieter, Sebastian M; Giessler, Klara M; Kriegsmann, Mark; Dubash, Taronish D; Möhrmann, Lino; Schulz, Erik R; Siegl, Christine; Weber, Sarah; Strakerjahn, Hendrik; Oberlack, Ava; Heger, Ulrike; Gao, Jianpeng; Hartinger, Eva-Maria; Oppel, Felix; Hoffmann, Christopher M; Ha, Nati; Brors, Benedikt; Lasitschka, Felix; Ulrich, Alexis; Strobel, Oliver; Schmidt, Manfred; von Kalle, Christof; Schneider, Martin; Weichert, Wilko; Ehrenberg, K Roland; Glimm, Hanno; Ball, Claudia R.
Afiliación
  • Dieter SM; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Giessler KM; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Kriegsmann M; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dubash TD; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Möhrmann L; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schulz ER; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Siegl C; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weber S; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Strakerjahn H; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Oberlack A; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Heger U; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Gao J; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hartinger EM; Department of Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Oppel F; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hoffmann CM; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ha N; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brors B; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lasitschka F; Department of Applied Bioinformatics, NCT Heidelberg and DKFZ, Heidelberg, Germany.
  • Ulrich A; Department of Applied Bioinformatics, NCT Heidelberg and DKFZ, Heidelberg, Germany.
  • Strobel O; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schmidt M; Department of Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • von Kalle C; Department of Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Schneider M; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weichert W; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Ehrenberg KR; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Glimm H; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Ball CR; Heidelberg Center for Personalized Oncology, DKFZ-HIPO, DKFZ, Heidelberg, Germany.
Int J Cancer ; 140(6): 1356-1363, 2017 03 15.
Article en En | MEDLINE | ID: mdl-27935045
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Ensayo de Capsula Subrrenal / Linfocitos B / Neoplasias Colorrectales / Infecciones por Virus de Epstein-Barr / Carcinoma Ductal Pancreático / Trastornos Linfoproliferativos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Int J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Ensayo de Capsula Subrrenal / Linfocitos B / Neoplasias Colorrectales / Infecciones por Virus de Epstein-Barr / Carcinoma Ductal Pancreático / Trastornos Linfoproliferativos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Int J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Alemania